Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

RLI

RLI Corp Reports 48.5% Increase in Q4 Net Earnings

RLI Corp. reported its fourth-quarter 2025 earnings in a conference call on January 22, 2026. The participants included Craig W. Kliethermes, President and Chief Executive Officer, Aaron P. Diefenthaler, Chief Financial Officer, and Jennifer L. Klobnak, Chief Operating Officer. Other participants from various financial institutions were also present.

In terms of financial performance, RLI Corp. reported a significant increase in net earnings for the fourth quarter of 2025, with a figure of $60.2 million, up from $40.4 million in the same period of the previous year. This represents an impressive 48.5% year-over-year growth in net earnings.

The company's underwriting income also demonstrated strong improvement, reaching $34.9 million in the fourth quarter of 2025, compared to $20.2 million for the same period in 2024. This indicates a substantial 72.8% increase in underwriting income year-over-year.

Additionally, RLI Corp.'s combined ratio, a key metric in the insurance industry, improved to 82.4% in the fourth quarter of 2025, down from 88.1% in the fourth quarter of 2024. This represents a noteworthy 5.7 percentage point reduction in the combined ratio, reflecting improved underwriting performance and operational efficiency.

Investment income for the company also saw positive growth, reaching $30.7 million in the fourth quarter of 2025, compared to $27.5 million in the same period of the prior year, marking a solid 11.6% increase in investment income year-over-year.

Moreover, RLI Corp.'s book value per share, a measure of the company's intrinsic worth, increased to $28.16 as of December 31, 2025, up from $25.85 at the end of 2024, indicating a robust 9.0% growth in book value per share.

Today the company's shares have moved -1.4% to a price of $59.35. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS